Norimasa Miyamoto

机构：Tohoku Institute of Technology, University of Tsukuba, Eisai (Japan) · ORCID：0000-0003-0391-1339

发表论文 82 篇 · 总被引 3820 次 · h-index 24

代表论文

A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes (2016 · Journal of Pharmacological and Toxicological Methods · 被引 186)
Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes (2015 · Journal of Pharmacological and Toxicological Methods · 被引 156)
CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia — Effects of 7 reference compounds at 10 facilities (2015 · Journal of Pharmacological and Toxicological Methods · 被引 93)
Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential (2016 · PLoS ONE · 被引 91)
Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative (2016 · Journal of Pharmacological and Toxicological Methods · 被引 59)
Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes (2018 · Journal of Pharmacological Sciences · 被引 41)